DiaPlexQ™ SARS-CoV-2 (ORF1a, N, RdRp)
Real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids in various sample types.
Simple, Fast, Sensitive.
Product number 81132
Click here to navigate
- Conditions of sale
- Related products
- Hot Start PCR: high specificity
- Detection Target: N and ORF1a genes
- OneStep PCR: multiple targets in a single reaction
- Reliable system: internal control RNase P
- Easy-to-use master mix: just adding template and Primer/Probe Mix
- Rapid detection: 75 minutes amplification
- Specimen Type: Nasopharyngeal, Oropharyngeal, Nasal, bronchoalveolar lavage (BAL) fluid, Sputum
- Applied BiosystemsTM 7500 Fast Real-Time PCR System
- Applied BiosystemsTM 7500 Real-Time PCR System
- Bio-Rad CFX96TM IVD Real-Time PCR System
- QuantStudioTM 5 Real-Time PCR System
- Adaptation to other thermal cyclers possible
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.
Jan 6, 2022
During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...
Oct 19, 2020
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
Aug 26, 2020
DiaPlexQ™ Flu A/B & SARS-CoV-2
Product number 81131 -
Real-time RT-PCR test for the qualitative detection of HA gene from Influenza A/B virus and N and ORF1a gene from SARS-CoV-2 in nasopharyngeal swab.CE marked
iAMP COVID-19 Detection Kit
Product number 80767, 80762 -
Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.CE marked
iAMP COVID-19 SANO Assay
Product number 81104, 80762, 80812 -
Qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.CE marked
Lumipulse® G SARS-CoV-2 Ag
Product number 260340, 231869 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.CE marked
Lumipulse® G SARS-CoV-2 N-IgG
Product number 232323 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma. SARS-CoV-2 N antibody measurement is intended to be used as an aid in the assessment of immune response to the SARS-CoV-2 N protein.CE marked
Lumipulse® G SARS-CoV-2 S-IgG
Product number 232231 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System.CE marked